HISHS-3001

N/A

Report date: 2024/08/09 10:36:07
NME

Base Information

Drug NameHISHS-3001
Drug Alias NameHISHS-3001HISHS-30
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonists
TargetsGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsObesityHyperglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSun Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsObesityHyperglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A